JP2021052944A - Suppository capsule material - Google Patents

Suppository capsule material Download PDF

Info

Publication number
JP2021052944A
JP2021052944A JP2019177500A JP2019177500A JP2021052944A JP 2021052944 A JP2021052944 A JP 2021052944A JP 2019177500 A JP2019177500 A JP 2019177500A JP 2019177500 A JP2019177500 A JP 2019177500A JP 2021052944 A JP2021052944 A JP 2021052944A
Authority
JP
Japan
Prior art keywords
suppository
capsule material
tip
rear end
tetra
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019177500A
Other languages
Japanese (ja)
Inventor
憲次 小森山
Kenji Komoriyama
憲次 小森山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2019177500A priority Critical patent/JP2021052944A/en
Publication of JP2021052944A publication Critical patent/JP2021052944A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)

Abstract

To prevent a suppository from dropping due to intestine and vaginal contraction or ejection of a body gas.SOLUTION: A suppository capsule material includes a tip tetra-part 12 serving as an insertion side and a columnar cylindrical part 15 continuously installed in a rear end of the tip tetra-part. The suppository capsule material is assumed as a technical premise, and a direction operation part 17 with a spherical surface is provided in the rear end of the columnar cylindrical part 15 (claim 1). By providing the direction operation part with the spherical surface, when the direction operation part positioned in the rear end is pushed in an appropriate direction of top/bottom and left/right directions in the insertion of the suppository, the spherical surface of the suppository capsule material slides between a body wall surface and itself, and the capsule material is turned. When the capsule material is turned to the insertion direction, the suppository can take a sideways-facing posture in the intestine or the vagina. While the tip surface of the tip tetra-part of the insertion side and the rear end surface of the direction operation part are brought into contact with the internal wall, the suppository capsule material is made to stay and is maintained. A contact pressure with the internal wall is high, and therefore dropping and the like are prevented from being caused in normal use.SELECTED DRAWING: Figure 1

Description

本発明は、坐剤用カプセル材に係り、特に、挿入した坐剤の抜け落ちを防止する形状技術に関する。 The present invention relates to a suppository capsule material, and more particularly to a shape technique for preventing the inserted suppository from falling off.

坐剤(挿入薬、座薬;以下坐剤という)は、腸内病、痔、その他の疾病の治療、解熱、鎮痛等を目的として体内に挿入して使用する。坐剤の挿入部位は、肛門または膣を利用することが多い。 Suppositories (insertions, suppositories; hereinafter referred to as suppositories) are used by inserting them into the body for the purpose of treating intestinal diseases, hemorrhoids, and other diseases, reducing fever, and analgesia. The anus or vagina is often used as the insertion site for suppositories.

坐剤は、水溶性のカプセル材に薬剤を封入して体内に差し込むので、カプセル材の形状は、従来、いわゆる弾丸形状または砲弾形状に成形し、体内にスムーズに挿入できるようにしている。 Since a suppository encloses a drug in a water-soluble capsule material and inserts the drug into the body, the shape of the capsule material is conventionally formed into a so-called bullet shape or a cannonball shape so that the suppository can be smoothly inserted into the body.

具体的には、例えば、図8に示すものがある(特許文献1)。 Specifically, for example, there is one shown in FIG. 8 (Patent Document 1).

この坐剤用カプセル材1は、挿入側となる先端テトラ部2と、先端テトラ部2の後端に連設させた柱状筒部3とを備える。先端テトラ部2は、挿入方向を前方としたきに後方に向かって径が暫時拡大する水平断面円形を呈しており、柱状筒部3は、水平断面径が略同一の筒状に成形される。 The suppository capsule material 1 includes a tip tetra portion 2 on the insertion side and a columnar cylinder portion 3 connected to the rear end of the tip tetra portion 2. The tip tetra portion 2 has a circular horizontal cross section whose diameter gradually expands toward the rear when the insertion direction is forward, and the columnar tubular portion 3 is formed into a tubular shape having substantially the same horizontal cross section diameter. ..

4は、先端テトラ部2の先端面から柱状筒部3の後端面まで貫く中空部(流通部)である。この中空部4は、腸内ガスによる坐剤の抜け落ちを防止する機能を営むものである。 Reference numeral 4 denotes a hollow portion (distribution portion) penetrating from the front end surface of the tip tetra portion 2 to the rear end surface of the columnar cylinder portion 3. The hollow portion 4 has a function of preventing the suppository from coming off due to intestinal gas.

体内に挿入した坐剤用カプセル材1は、挿入部位の体内壁部と密着し、体内壁部との摩擦により挿入部位に停滞する。一定時間が経過して、坐剤用カプセル材1が溶けると、内部の薬剤が外部に流出し、体内壁部を介して薬品成分が吸収され体内に送られる。 The suppository capsule material 1 inserted into the body is in close contact with the internal wall portion of the insertion site and stays at the insertion site due to friction with the internal wall portion. When the suppository capsule material 1 melts after a certain period of time, the internal drug flows out, and the drug component is absorbed through the body wall and sent into the body.

特開平5−279243号Japanese Patent Application Laid-Open No. 5-279243

問題は、従来の坐剤は、挿入部位から抜け落ちしやすいことにある。 The problem is that conventional suppositories tend to fall out of the insertion site.

従来の坐剤は、カプセル材と体内壁部との密着によって挿入部位に留まることを前提とするが、姿勢を変える等、なんらかの事由で腸や膣が収縮した場合には、坐剤用カプセル材の外周面が絞り出されるように滑動し、体外に抜け出してしまうことが少なくない。 Conventional suppositories are premised on staying at the insertion site due to the close contact between the capsule material and the body wall, but if the intestine or vagina contracts for some reason such as changing posture, the suppository capsule material It slides so that the outer peripheral surface of the capsule is squeezed out, and often slips out of the body.

特許文献1の発明は、体内ガスの放出時に、体内ガスを中空部(流通部)から逃がすことが出来るため、体内ガスに起因する抜け落ちは防止できる。 In the invention of Patent Document 1, since the body gas can be released from the hollow portion (circulation part) when the body gas is released, it is possible to prevent the body gas from falling out due to the body gas.

しかしながら、腸や膣の収縮等によるカプセル材の滑動、押し出しを防止することは困難である。 However, it is difficult to prevent the capsule material from sliding or pushing out due to contraction of the intestine or vagina.

そこで、本発明の目的は、腸や膣の収縮、体内ガスの放出等による坐剤の抜け落ちを防止する点にある。 Therefore, an object of the present invention is to prevent the suppository from falling off due to contraction of the intestine or vagina, release of gas in the body, or the like.

前記目的を達成するため、本発明に係る坐剤用カプセル材は、挿入側となる先端テトラ部と、当該先端テトラ部の後端に連設させた柱状筒部とを備える坐剤用カプセル材を技術的前提として、前記柱状筒部の後端部に、球状面を呈する方向操作部を設ける(請求項1)。 In order to achieve the above object, the suppository capsule material according to the present invention is a suppository capsule material including a tip tetra portion on the insertion side and a columnar tubular portion connected to the rear end of the tip tetra portion. As a technical premise, a directional control portion having a spherical surface is provided at the rear end portion of the columnar cylinder portion (claim 1).

球状面を呈する方向操作部を設けることにより、坐剤の挿入時に、後端部に位置する方向操作部を上下左右の適宜方向に押し込むと、坐剤用カプセル材の球状面が体内壁面との間で滑り、坐剤用カプセル材が回動する。 By providing a directional control portion that exhibits a spherical surface, when the suppository is inserted, the directional control portion located at the rear end is pushed in the appropriate directions up, down, left, and right, and the spherical surface of the suppository capsule material is brought into contact with the internal wall surface. It slips between them and the suppository capsule material rotates.

適当角度、例えば挿入方向に対して略90度、坐剤用カプセル材を回動させると、坐剤は、腸または膣内で横向きの姿勢をとることが出来る。 When the suppository capsule material is rotated at an appropriate angle, for example, approximately 90 degrees with respect to the insertion direction, the suppository can take a sideways posture in the intestine or vagina.

この場合、挿入側の先端テトラ部の先端面と、球状を呈する方向操作部の後端面とが、体内壁と接触した状態で坐剤用カプセル材が滞留維持される。接触面積は少ないが、体内壁との接触圧が高いので、通常使用時における不具合(抜け落ち等)は生じない。 In this case, the suppository capsule material is retained and maintained in a state where the tip surface of the tip tetra portion on the insertion side and the rear end surface of the directional control portion exhibiting a spherical shape are in contact with the body wall. Although the contact area is small, the contact pressure with the body wall is high, so that problems (such as falling off) during normal use do not occur.

他方、坐剤用カプセル材が横向き姿勢をとることが出来るため、何らかの理由で腸や膣が収縮しても、坐剤用カプセル材と体内壁の接触面積が少ない結果、滑動による坐剤の押し出し、抜け落ちは生じにくくなる。 On the other hand, since the suppository capsule material can take a sideways posture, even if the intestine or vagina contracts for some reason, the contact area between the suppository capsule material and the body wall is small, and as a result, the suppository is pushed out by sliding. , It is less likely to fall out.

方向操作部の表面に、複数の凹部を形成する場合がある(請求項2)。 A plurality of recesses may be formed on the surface of the directional control unit (claim 2).

坐剤を指で押し込むときに、球面と触れている指が滑る可能性があるため、球状面に若干の複数の凹部を設けておけば、指の滑りが抑えられ、挿入時における坐剤の方向操作がしやすくなる。 When pushing the suppository with a finger, the finger touching the spherical surface may slip. Therefore, if a few recesses are provided on the spherical surface, the finger slippage can be suppressed and the suppository can be inserted. It becomes easier to operate the direction.

方向操作部は、球状面を備えていればよく、必ずしも完全な球体である必要はない。挿入時に、坐剤の挿入角度に変更を与えることが出来れば、方向操作部を設ける目的は達成できるからである。球体に近い形状、後端部を適当箇所で水平にカットする等、後端部の形状は適宜設計できる。 The directional control unit need only have a spherical surface, and does not necessarily have to be a perfect sphere. This is because the purpose of providing the directional control portion can be achieved if the insertion angle of the suppository can be changed at the time of insertion. The shape of the rear end can be appropriately designed, such as a shape close to a sphere and the rear end being cut horizontally at an appropriate position.

本発明に係る坐剤用カプセル材によれば、腸や膣の収縮、体内ガスの放出等による坐剤の抜け落ちを防止することが出来る。 According to the capsule material for suppositories according to the present invention, it is possible to prevent the suppository from falling off due to contraction of the intestine or vagina, release of gas in the body, or the like.

第一の実施形態に係る坐剤用カプセル材を側面から示す図である。It is a figure which shows the suppository capsule material which concerns on 1st Embodiment from the side. 図1に示す坐剤用カプセル材の平面図である。It is a top view of the suppository capsule material shown in FIG. 図1に示す坐剤用カプセル材の挿入例を示す図である。It is a figure which shows the insertion example of the capsule material for a suppository shown in FIG. 図1に示す坐剤用カプセル材を横転させた使用状態を例示する図である。It is a figure which illustrates the use state in which the suppository capsule material shown in FIG. 1 is rolled over. 第二の実施形態に係る坐剤用カプセル材を側面から示す図である。It is a figure which shows the suppository capsule material which concerns on 2nd Embodiment from the side. 図5に示す坐剤用カプセル材の底面図である。It is a bottom view of the suppository capsule material shown in FIG. 第三の実施形態に係る坐剤用カプセル材を側面から示す図である。It is a figure which shows the suppository capsule material which concerns on 3rd Embodiment from the side. 従来の坐剤用カプセル材を示す図である。It is a figure which shows the conventional capsule material for a suppository.

図1、図2は、本発明に係る坐剤用カプセル材の第一実施形態を示すものである。 1 and 2 show the first embodiment of the suppository capsule material according to the present invention.

11は、坐剤用カプセル材であり、この坐剤用カプセル材11に薬剤を装填して坐剤(挿入薬)10が出来る。 Reference numeral 11 denotes a suppository capsule material, and the suppository (insertion agent) 10 can be prepared by loading the suppository capsule material 11 with a drug.

12は、坐剤10の挿入側となる先端テトラ部、13は、先端テトラ部12の先端面、15は、先端テトラ部12の後端に連設させた柱状筒部である。 Reference numeral 12 denotes a tip tetra portion on the insertion side of the suppository 10, 13 is a tip surface of the tip tetra portion 12, and 15 is a columnar cylinder portion continuously provided at the rear end of the tip tetra portion 12.

17は、柱状筒部15の後端部に設けた、球状面を呈する方向操作部である。この実施形態では、方向操作部17は、後端部も球面状である略球形に成形してある。 Reference numeral 17 denotes a directional control portion having a spherical surface provided at the rear end portion of the columnar tubular portion 15. In this embodiment, the directional control portion 17 is formed into a substantially spherical shape whose rear end portion is also spherical.

従来の坐剤用カプセル材と同様、先端テトラ部12および柱状筒部15の形状/寸法は、必要に応じて小さな変更を加えることが出来る。例えば、先端テトラ部12の先端面13を湾曲面としても良いし、柱状筒部15は長手方向の中間部を若干細く成形する等である。 Similar to the conventional capsule material for suppositories, the shapes / dimensions of the tip tetra portion 12 and the columnar tubular portion 15 can be slightly changed as needed. For example, the tip surface 13 of the tip tetra portion 12 may be a curved surface, and the columnar tubular portion 15 may have a slightly thinner intermediate portion in the longitudinal direction.

従来の坐剤用カプセル材は、先端テトラ部12の先端面13から柱状筒部15の後端面までの寸法が、約30mm程度であるが、本実施形態に係る坐剤用カプセル材11は略球形の方向操作部17を備えるため、柱状筒部15の長手寸法は若干短めに成形することが好ましい。 The conventional capsule material for suppositories has a dimension of about 30 mm from the tip surface 13 of the tip tetra portion 12 to the rear end surface of the columnar cylinder portion 15, but the capsule material 11 for suppositories according to the present embodiment is omitted. Since the spherical directional control portion 17 is provided, the longitudinal dimension of the columnar tubular portion 15 is preferably formed to be slightly shorter.

方向操作部17は、例えば、柱状筒部15の後端部に連設させて成形する。この方向操作部17は、坐剤用カプセル材11の挿入方向を変えるための手段であり、内部に薬剤を装填する必要はない。内部に薬剤が装填されることを前提とする場合は、略球形の方向操作部17と柱状筒部15とは空間的に連通させておく。一方、方向操作部17に薬剤を装填しない場合は、柱状筒部15の後端面または方向操作部17の接続面は閉じて良い。但し、体内での融解を速やかにするため方向操作部17は内部中空に成形することが望ましい。 The directional control portion 17 is formed by being continuously provided with, for example, the rear end portion of the columnar cylinder portion 15. The directional control unit 17 is a means for changing the insertion direction of the suppository capsule material 11, and it is not necessary to load the drug inside. When it is assumed that the drug is loaded inside, the substantially spherical directional control portion 17 and the columnar cylinder portion 15 are spatially communicated with each other. On the other hand, when the chemical is not loaded into the directional control unit 17, the rear end surface of the columnar cylinder portion 15 or the connection surface of the directional control unit 17 may be closed. However, it is desirable that the directional control unit 17 is formed into a hollow inside in order to expedite melting in the body.

方向操作部17の寸法は、柱状筒部15に比して若干大きめに設計することが望ましい。例えば、柱状筒部15の短手寸法(外寸)を10mmとしたとき、方向操作部17の直径(外寸)を15mmとする等である。坐剤10の種類や目的に応じて、柱状筒部15の大きさも変わるので、柱状筒部15の大きさに応じて方向操作部17の直径も適宜変更する。 It is desirable that the size of the directional control portion 17 is designed to be slightly larger than that of the columnar cylinder portion 15. For example, when the short side dimension (outer dimension) of the columnar cylinder portion 15 is 10 mm, the diameter (outer dimension) of the directional control portion 17 is set to 15 mm. Since the size of the columnar cylinder portion 15 also changes depending on the type and purpose of the suppository 10, the diameter of the directional control portion 17 is also appropriately changed according to the size of the columnar cylinder portion 15.

直径を大きくするほど、指で方向を操作する方向操作部17の操作性は向上するが、体内に挿入するものであるから過剰に大きくすることは困難である。好ましくは、例えば、柱状筒部15の短手寸法に対して方向操作部17の直径は30〜60%増程度に抑える。 The larger the diameter, the better the operability of the directional control unit 17 for manipulating the direction with a finger, but it is difficult to make it excessively large because it is inserted into the body. Preferably, for example, the diameter of the directional control portion 17 is suppressed to about 30 to 60% larger than the lateral dimension of the columnar cylinder portion 15.

坐剤用カプセル材11の原料は、従来の坐剤と同様、例えば、ゼラチン、ヒドロキシプロピルメチルセルロースなどを用いることが出来る。強度や安全性の理由でゼラチン使用が好ましい。安全性と強度保証ができる水溶性素材であれば、原料は適宜選択使用することが出来る。 As the raw material of the capsule material 11 for suppositories, for example, gelatin, hydroxypropylmethyl cellulose and the like can be used as in the case of conventional suppositories. Gelatin is preferred for strength and safety reasons. As long as it is a water-soluble material that can guarantee safety and strength, the raw material can be appropriately selected and used.

かかる構成によれば、坐剤10を体内(例えば直腸R)に挿入するときに、図3に示すように、方向操作部17を、例えば矢印Aに回動させることによって、坐剤10の先端を矢印Aとは逆方向に回動させることが出来る。方向操作部17は略球体なので、指による操作に従動して直腸内で滑らかに回動するからである。 According to this configuration, when the suppository 10 is inserted into the body (for example, rectum R), as shown in FIG. 3, the tip of the suppository 10 is rotated by rotating the directional control unit 17 in the direction of the arrow A, for example. Can be rotated in the direction opposite to the arrow A. This is because the directional control unit 17 is a substantially sphere, so that it rotates smoothly in the rectum in accordance with the operation by the finger.

最終的に、例えば図4に示すように、坐剤10が直腸R内で横向きになったときは、先端テトラ部12の先端面13と方向操作部17の後端部が、直腸Rの内壁に当接し、直腸Rの圧によって挟まれた状態で体内に留まる。 Finally, as shown in FIG. 4, for example, when the suppository 10 is turned sideways in the rectum R, the tip surface 13 of the tip tetra portion 12 and the rear end portion of the directional control portion 17 are the inner wall of the rectum R. And stays in the body in a state of being sandwiched by the pressure of the rectum R.

横向きになって留まった坐剤10は、直腸Rの収縮によっては動きにくく、体外に抜け落ちる可能性が格段に小さくなる。従来の坐剤は、直腸Rとの摩擦によって体内に留まっていた。このため、直腸Rが収縮したときは蠕動運動によって体外に滑り落ち易かった。しかし、坐剤10が横向きになった場合は、収縮による蠕動運動も生じにくい。最初から、直腸Rの圧を受けつつ挟まれて留まっているからである。 The suppository 10 that stays sideways is difficult to move due to the contraction of the rectum R, and the possibility of falling out of the body is significantly reduced. Conventional suppositories stay in the body due to friction with the rectal R. Therefore, when the rectum R contracted, it was easy to slip out of the body due to peristaltic movement. However, when the suppository 10 is turned sideways, peristaltic movement due to contraction is unlikely to occur. This is because from the beginning, it is sandwiched and stays under the pressure of the rectum R.

坐剤10が直腸Rに対して直角方向の姿勢をとっている場合、坐剤10の周囲には空間的な余裕がある。従って、体内ガスは、坐剤10に遮られずに体外に排出できる。 When the suppository 10 is in a posture perpendicular to the rectum R, there is a space around the suppository 10. Therefore, the gas in the body can be discharged to the outside of the body without being blocked by the suppository 10.

なお、図3では、理解の容易のため直腸Rと坐剤10との間に隙間があるように示したが、実際には、隙間はない。また図4では、坐剤10の周りの直腸Rの広がりを誇張して描いてあるが、実際には、横向きの坐剤10の部分だけが局所的に広がるだけである。坐剤用カプセル材11が融解するまでの短時間かつ限定的な広がりなので、直腸Rを損傷させる等の問題は生じない。 In FIG. 3, it is shown that there is a gap between the rectum R and the suppository 10 for easy understanding, but in reality, there is no gap. Further, in FIG. 4, the spread of the rectum R around the suppository 10 is exaggerated, but in reality, only the portion of the sideways suppository 10 is locally spread. Since the suppository capsule material 11 spreads in a short time and in a limited manner until it melts, problems such as damage to the rectal R do not occur.

図5、図6は、第二の実施形態に係る坐剤用カプセル材21を示すものである。 5 and 6 show the suppository capsule material 21 according to the second embodiment.

この坐剤用カプセル材21は、方向操作部27を略半球形に成形し、方向操作部27の後端面28を平板面にしたものである(図5参照)。先端テトラ部12および柱状筒部15は、第一の実施形態と同様であるから同一符号を附して重複する説明を省略する。 In this suppository capsule material 21, the directional control portion 27 is formed into a substantially hemispherical shape, and the rear end surface 28 of the directional control portion 27 is made into a flat plate surface (see FIG. 5). Since the tip tetra portion 12 and the columnar tubular portion 15 are the same as those in the first embodiment, they are designated by the same reference numerals and duplicated description will be omitted.

方向操作部27は、坐剤10の挿入角度を変化させる機能があればよい。第一の実施形態に示すように、略球形とするのが最も望ましいが、半球形であっても球状面は直腸R内で滑らかに回動し、坐剤10を直腸Rに対して略直角の姿勢をとらせることが出来る。 The directional control unit 27 may have a function of changing the insertion angle of the suppository 10. As shown in the first embodiment, it is most desirable to make it substantially spherical, but even if it is hemispherical, the spherical surface rotates smoothly in the rectum R, and the suppository 10 is substantially perpendicular to the rectum R. You can take the posture of.

半球形とする利点は、長手寸法の短縮によるパッケージケースの小型化、それに伴う輸送、収納の効率化がある。 The advantage of the hemispherical shape is that the package case can be made smaller by shortening the longitudinal dimension, and the efficiency of transportation and storage can be improved accordingly.

半球形の方向操作部27は、球状面の面積を大きくとるため、球体中心点より若干後方に後端面28を設けることが望ましい(図6参照)。 In order to increase the area of the spherical surface of the hemispherical directional control unit 27, it is desirable to provide the rear end surface 28 slightly behind the center point of the sphere (see FIG. 6).

また、半球形の方向操作部27とする場合、後端面28は平板状ではなく、円錐形等、適宜形状に成形しても良い。 Further, in the case of the hemispherical directional control portion 27, the rear end surface 28 may be formed into an appropriate shape such as a conical shape instead of a flat plate shape.

図7は、第三の実施形態に係る坐剤用カプセル材31を示すものである。 FIG. 7 shows the suppository capsule material 31 according to the third embodiment.

この坐剤用カプセル材31は、略球形の方向操作部37の表面に、複数の凹部38を形成するものである。これは、指によって略球形の方向操作部37を操作するときに、指の滑りを防止するためである。その他の構成は第一の実施形態と同じであるから、同一符号を附して重複する説明を省略する。 The suppository capsule material 31 forms a plurality of recesses 38 on the surface of the substantially spherical directional control portion 37. This is to prevent the finger from slipping when the substantially spherical directional control unit 37 is operated by the finger. Since the other configurations are the same as those in the first embodiment, the same reference numerals are given and duplicate description will be omitted.

凹部は、指の滑りを防止できるよう、複数設ける。指の滑りを防止できれば良いので、凹部38は深く形成する必要はなく、小さな浅い湾曲窪みで良い。凹部38の外観形状は、円、楕円、矩形いずれでも良い。 A plurality of recesses are provided so as to prevent the fingers from slipping. The recess 38 does not need to be formed deeply as long as it can prevent the finger from slipping, and a small shallow curved recess may be used. The external shape of the recess 38 may be a circle, an ellipse, or a rectangle.

10 坐剤(挿入薬)
11、21、31 坐剤用カプセル材
12 先端テトラ部
13 先端テトラ部の先端面
15 柱状筒部
17、27、37 方向操作部
28 (方向操作部の)後端面
38 凹部
R 直腸
10 Suppository (insertion drug)
11, 21, 31 Capsule material for suppository 12 Tip tetra part 13 Tip surface of tip tetra part 15 Columnar cylinder part 17, 27, 37 Directional operation part 28 Rear end surface (of directional operation part) 38 Concave R rectum

Claims (2)

挿入側となる先端テトラ部と、
当該先端テトラ部の後端に連設させた柱状筒部とを備える坐剤用カプセル材において、
前記柱状筒部の後端部に、
球状面を呈する方向操作部を設けることを特徴とする坐剤用カプセル材。
The tip tetra part on the insertion side and
In a suppository capsule material provided with a columnar tubular portion connected to the rear end of the tip tetra portion.
At the rear end of the columnar cylinder
A suppository capsule material characterized by providing a directional control portion that exhibits a spherical surface.
方向操作部の表面に、
複数の凹部を形成することを特徴とする請求項1記載の坐剤用カプセル材。
On the surface of the directional control unit
The capsule material for a suppository according to claim 1, wherein a plurality of recesses are formed.
JP2019177500A 2019-09-27 2019-09-27 Suppository capsule material Pending JP2021052944A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019177500A JP2021052944A (en) 2019-09-27 2019-09-27 Suppository capsule material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019177500A JP2021052944A (en) 2019-09-27 2019-09-27 Suppository capsule material

Publications (1)

Publication Number Publication Date
JP2021052944A true JP2021052944A (en) 2021-04-08

Family

ID=75271578

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019177500A Pending JP2021052944A (en) 2019-09-27 2019-09-27 Suppository capsule material

Country Status (1)

Country Link
JP (1) JP2021052944A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58208213A (en) * 1982-05-11 1983-12-03 サ−ルバ−ト−レイ・ジエイ・デトラノ Anus suppository for treating anus disease and method
JP3067971U (en) * 1999-05-25 2000-04-21 エーザイ株式会社 Suppository with distinctiveness
JP2000288018A (en) * 1999-04-02 2000-10-17 Alcare Co Ltd Dressing for anus
US20080167596A1 (en) * 2006-06-15 2008-07-10 Jiro Takashima Hemorrhoid treatment suppository
JP2010520300A (en) * 2007-03-05 2010-06-10 二郎 高島 Hemorrhoid treatment suppository
US20170266423A1 (en) * 2014-05-26 2017-09-21 Urobrain Gmbh Medicament carrier for the treatment and prevention of pathological conditions in the urogenital region

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58208213A (en) * 1982-05-11 1983-12-03 サ−ルバ−ト−レイ・ジエイ・デトラノ Anus suppository for treating anus disease and method
JP2000288018A (en) * 1999-04-02 2000-10-17 Alcare Co Ltd Dressing for anus
JP3067971U (en) * 1999-05-25 2000-04-21 エーザイ株式会社 Suppository with distinctiveness
US20080167596A1 (en) * 2006-06-15 2008-07-10 Jiro Takashima Hemorrhoid treatment suppository
JP2010520300A (en) * 2007-03-05 2010-06-10 二郎 高島 Hemorrhoid treatment suppository
US20170266423A1 (en) * 2014-05-26 2017-09-21 Urobrain Gmbh Medicament carrier for the treatment and prevention of pathological conditions in the urogenital region

Similar Documents

Publication Publication Date Title
JP2019506230A5 (en)
EP2301512B1 (en) Tube for gastrointestinal tract
JP4332532B2 (en) Drug administration device
JP2021052944A (en) Suppository capsule material
US20210077115A1 (en) Multi-Band Rubber Band Ligation Device And Method Of Operation Thereof
CN212593456U (en) Balloon catheter
KR102009567B1 (en) Plasma Treatment Device
US11298515B2 (en) Single-use suppository insertion device and method
CN104027882A (en) Baloon Catheter Inflation
US3840010A (en) Suppository
US20200323699A1 (en) Medication Delivery Device and Method
WO2024007467A1 (en) Implant release mechanism and delivery apparatus
CN106214107A (en) Active exercise unit for electromagnetic drive type intestinal microrobot
CN108273180A (en) A kind of gynaecology's Special medicine applicator
JP6476357B1 (en) Overtube
KR102328800B1 (en) Gibs unit enable to refill medication
JP3529392B2 (en) Insertion medicine
EP2120867A1 (en) Hemorrhoid treatment suppository
TWM587511U (en) Plug and insemination tube with semen backflow prevention for artificial insemination of pig
KR101846532B1 (en) Nasolacrimal duct tube and insertion appliance for nasolacrimal duct
US20180199925A1 (en) Plug for amniotic recovery
US20230414403A1 (en) Contraception apparatus for male
CN109589488A (en) Intestinal obstruction dredge
KR20190108221A (en) Urethal Catheter
WO2023040323A1 (en) Prosthetic valve delivery system, stopper, and interventional delivery device

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200630

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210608

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20211207